These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20472580)

  • 21. Diagnostic strategy to monitor diabetic nephropathy.
    Rowe DJ; Twyman S
    Kidney Int Suppl; 1994 Nov; 47():S109-10. PubMed ID: 7869658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.
    Hinokio Y; Suzuki S; Hirai M; Suzuki C; Suzuki M; Toyota T
    Diabetologia; 2002 Jun; 45(6):877-82. PubMed ID: 12107732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microalbuminuria in non-insulin dependent diabetes and essential hypertension--a marker of severe disease.
    Ahmed S
    J Assoc Physicians India; 1995 Jul; 43(7):517-8. PubMed ID: 8713236
    [No Abstract]   [Full Text] [Related]  

  • 24. Exercise induced proteinuria as an early indicator of diabetic nephropathy.
    Agarwal RP; Thanvi I; Vachhani G; Kochar DK; Rastogi A
    J Assoc Physicians India; 1998 Sep; 46(9):772-4. PubMed ID: 11229244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cigarette smoking on urinary podocyte excretion in early diabetic nephropathy.
    Nakamura T; Kawagoe Y; Koide H
    Diabetes Care; 2003 Apr; 26(4):1324-5. PubMed ID: 12663629
    [No Abstract]   [Full Text] [Related]  

  • 26. Tubular dysfunction in the early stage of diabetic nephropathy.
    Tanaka A; Shima K; Fukuda M; Tahara Y; Yamamoto Y; Kumahara Y
    Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proteinuria in diabetics].
    Vörös P; Kammerer L; Miltényi M; Körner A; Németh C
    Orv Hetil; 1985 Sep; 126(38):2327-31. PubMed ID: 4047637
    [No Abstract]   [Full Text] [Related]  

  • 28. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats.
    Ogawa M; Hirawa N; Tsuchida T; Eguchi N; Kawabata Y; Numabe A; Negoro H; Hakamada-Taguchi R; Seiki K; Umemura S; Urade Y; Uehara Y
    Nephrol Dial Transplant; 2006 Apr; 21(4):924-34. PubMed ID: 16384826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of elevated serum uric acid with coronary heart disease in diabetes mellitus.
    Rathmann W; Hauner H; Dannehl K; Gries FA
    Diabete Metab; 1993; 19(1 Pt 2):159-66. PubMed ID: 8314420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy.
    Chen H; Zheng Z; Li R; Lu J; Bao Y; Ying X; Zeng R; Jia W
    Am J Nephrol; 2010; 32(1):47-56. PubMed ID: 20523035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
    Nakamura T; Fujiwara N; Sugaya T; Ueda Y; Koide H
    Metabolism; 2009 Aug; 58(8):1185-90. PubMed ID: 19481229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF; Mora C; Muros M; García J
    Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary beta-glucuronidase excretion in insulin-dependent diabetes mellitus: relation with diabetic nephropathy.
    Rodríguez-Cuartero A; Barcelona-Martín F
    Clin Nephrol; 1997 Aug; 48(2):135-6. PubMed ID: 9285156
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary N-acetyl-beta-glucosaminidase excretion in non-insulin-dependent diabetes mellitus: relation with diabetic nephropathy.
    Pérez-Blanco FJ; Sabatel-Hernández G; Cantero-Hinojosa J; Rodriguez-Cuartero A
    Clin Nephrol; 1998 Feb; 49(2):132-4. PubMed ID: 9524787
    [No Abstract]   [Full Text] [Related]  

  • 35. Proteomic analysis for the assessment of diabetic renal damage in humans.
    Mischak H; Kaiser T; Walden M; Hillmann M; Wittke S; Herrmann A; Knueppel S; Haller H; Fliser D
    Clin Sci (Lond); 2004 Nov; 107(5):485-95. PubMed ID: 15281910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
    Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
    Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and treatment of diabetic renal disease.
    Clement JD; Cottiero RA
    Med Health R I; 1998 Nov; 81(11):348-9. PubMed ID: 15580788
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical points in urinary proteomics.
    Thongboonkerd V
    J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.